Update: The deadline has been extended until November 2023
The Patrick Wild Centre is currently running the RECONNECT clinical trial for children and adolescents with fragile X syndrome.
The link below will take you to a website with more information about the trial and a place to enter your details if you are thinking of participating. Or feel free to just contact us directly at email@example.com
Learn more about a clinical trial evaluating investigational topical cannabidiol (CBD) gel to see if it helps behavioural issues related to Fragile X syndrome.
Potential participants need to be:
- Between 3 and 17 years of age
- Diagnosed via genetic testing, with Fragile X syndrome
- In generally good health
Follow the link to find out more: Reconnect Fragile X Syndrome Research Study in UK | Zynerba (fragilexhelp.co.uk)